96 related articles for article (PubMed ID: 8960547)
21. Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation.
Bjermer L
J Allergy Clin Immunol; 2007 Dec; 120(6):1269-75. PubMed ID: 18073122
[TBL] [Abstract][Full Text] [Related]
22. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
23. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
[TBL] [Abstract][Full Text] [Related]
24. Syntheses of immunomodulating androstanes and stigmastanes: comparison of their TNF-alpha inhibitory activity.
Ramírez JA; Bruttomesso AC; Michelini FM; Acebedo SL; Alché LE; Galagovsky LR
Bioorg Med Chem; 2007 Dec; 15(24):7538-44. PubMed ID: 17892941
[TBL] [Abstract][Full Text] [Related]
25. Influence of 16 alpha, 17 alpha-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids.
Brattsand R; Thalén A; Roempke K; Källström L; Gruvstad E
J Steroid Biochem; 1982 Jun; 16(6):779-86. PubMed ID: 7109581
[TBL] [Abstract][Full Text] [Related]
26. Basal and glucocorticoid induced changes of hepatic glucocorticoid receptor during aging: relation to activities of tyrosine aminotransferase and tryptophan oxygenase.
Ribarac-Stepić N; Vulović M; Korićanac G; Isenović E
Biogerontology; 2005; 6(2):113-31. PubMed ID: 16034679
[TBL] [Abstract][Full Text] [Related]
27. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
[TBL] [Abstract][Full Text] [Related]
28. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
Gierse J; Nickols M; Leahy K; Warner J; Zhang Y; Cortes-Burgos L; Carter J; Seibert K; Masferrer J
Eur J Pharmacol; 2008 Jun; 588(1):93-8. PubMed ID: 18457826
[TBL] [Abstract][Full Text] [Related]
30. [Inhaled glucocorticosteroids in treatment of bronchial asthma].
Piotrowska B; Droszcz W
Pol Merkur Lekarski; 1997 Feb; 2(8):126-8. PubMed ID: 9538658
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Stahn C; Löwenberg M; Hommes DW; Buttgereit F
Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
[TBL] [Abstract][Full Text] [Related]
33. Steroidal C-21 mercapto derivatives as dissociated steroids: discovery of an inhaled dissociated steroid.
Biju P; McCormick K; Aslanian R; Berlin M; Solomon D; Chapman R; McLeod R; Prelusky D; Eckel S; Kelly G; Natiello M; House A; Fernandez X; Bitar R; Phillips J; Anthes J
Bioorg Med Chem Lett; 2011 Nov; 21(21):6343-7. PubMed ID: 21944381
[TBL] [Abstract][Full Text] [Related]
34. Solid-phase synthesis of model libraries of 3alpha,17beta-dihydroxy-16alpha-(aminoethyl-N-substituted)-5alpha-androstanes for the development of steroidal therapeutic agents.
Maltais R; Mercier C; Labrie F; Poirier D
Mol Divers; 2005; 9(1-3):67-79. PubMed ID: 15789554
[TBL] [Abstract][Full Text] [Related]
35. [Clinical study of the hepatic tolerance of a new synthetic androgen: 1 alpha-methyl-5alpha-androstan-17beta-olo-3-one(mesterolone)].
Piccinino F; Balestrieri GG
Clin Ter; 1969 Sep; 50(6):519-25. PubMed ID: 5406049
[No Abstract] [Full Text] [Related]
36. Microbiological decomposition of 17alpha-methyl-17beta-hydroxy steroids with androstane nucleus.
Büki KG; Ambrus G; Szabó A
Acta Microbiol Acad Sci Hung; 1969; 16(3):253-9. PubMed ID: 5379587
[No Abstract] [Full Text] [Related]
37. Pyrolysis of 17-oxygenated 16-methylene-20-oxosteroids. 3. Preparation and pyrolysis of 17alpha-acetoxy-17beta-methyl-16-methylene-17alpha-oxo-D-homoandrostanes.
Popper TL; Carlon FE; Gnoj O
J Chem Soc Perkin 1; 1970; 10():1352-4. PubMed ID: 5464761
[No Abstract] [Full Text] [Related]
38. Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids).
Biju P; Wang H; Anthes J; McCormick K; Aslanian R; Berlin M; Bitar R; Lim YH; Lee YJ; Prelusky D; Mcleod R; Jia Y; Fernandez X; Lieber G; Jimenez J; Eckel S; House A; Chapman R; Phillips J
Bioorg Med Chem Lett; 2012 May; 22(9):3291-5. PubMed ID: 22465636
[TBL] [Abstract][Full Text] [Related]
39. Steroid side-chain oxazolidines.
Agnello EJ; Farina PR
J Med Chem; 1972 Apr; 15(4):363-5. PubMed ID: 5019550
[No Abstract] [Full Text] [Related]
40. 3-Substituted 2',3'-dihydroestra-1,3,5(10)-trieno (16alpha, 17alpha-b)furan-17beta-ols as potential estrogens.
Dinner A; Bishara RH; Rutherford BS
J Med Chem; 1975 Mar; 18(3):314-5. PubMed ID: 1133824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
